GSK
GSK plc
NYSE · Healthcare · Drug Manufacturers - General · GB
$49.89
−1.93%Institutional positioning
13F filings over the trailing two quarters
New 254Increased 696Reduced 742Sold out 87
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 67,661,646 | May 15, 2026 |
| FMR LLC | Reduced | 64,961,641 | Aug 13, 2026 |
| DODGE & COX | Reduced | 58,662,974 | May 14, 2026 |
| DODGE & COX | Reduced | 48,197,514 | Aug 13, 2026 |
| Fisher Asset Management, LLC | Increased | 35,722,792 | Aug 4, 2026 |
| FISHER ASSET MANAGEMENT, LLC | Increased | 34,522,363 | May 5, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Increased | 25,204,538 | May 11, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | Reduced | 25,182,068 | Aug 14, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 11,797,085 | May 13, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 11,717,613 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 11,396,249 | Aug 14, 2026 |
| MORGAN STANLEY | Reduced | 11,030,651 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 10,289,114 | May 15, 2026 |
| JTC EMPLOYER SOLUTIONS TRUSTEE LTD | Reduced | 9,042,389 | May 19, 2026 |
| JTC Employer Solutions Trustee Ltd | Reduced | 8,592,987 | Jul 31, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings